Drug intelligence / Profile preview

N-chlorotaurine

Development stage
Unknown
Lead developer
Pathogenics
Modality
Small Molecules
Administration
Topical, Ophthalmic, Otic, Intranasal
01

Overview

N-chlorotaurine is a long-lived oxidant and the N-chloro derivative of the amino acid taurine, naturally produced by activated human granulocytes and monocytes as part of the immune response[1][3]. It acts as a mild oxidizing antiseptic with broad-spectrum antimicrobial activity against bacteria, fungi, viruses (including SARS-CoV-2, influenza viruses, RSV), and parasites[3][8]. Its mechanism involves chlorination and oxidation of pathogen proteins and enzymes, leading to inactivation of virulence factors (microbiostatic effect), loss of pathogen viability or virulence (post-antibiotic effect), and delayed regrowth[6][8]. Additionally, it inhibits inducible nitric oxide synthase and IkappaB kinase[2][4], contributing to its anti-inflammatory properties. N-chlorotaurine can be synthesized chemically for topical application at various body sites (e.g., eye, skin ulcers, ear canal, nasal sinuses) with excellent tissue tolerability demonstrated in Phase I/II studies for conditions such as external otitis, skin ulcerations, keratoconjunctivitis, conjunctivitis, acanthamoeba keratitis[3][5]. C-methylated derivatives have been developed for improved stability.

Other names
n-chlorotaurinetaurine chloraminetaurochloraminetaurine monochloramine2-(chloroamino)ethanesulfonic acid
02

Targets

NOS2 (Nitric Oxide Synthase 2)CHUK (IKKα)

Beyond the preview

Go deeper on N-chlorotaurine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-chlorotaurine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call